SCM
HRTX icon

Suvretta Capital Management’s Heron Therapeutics HRTX Stock Holding History

Suvretta Capital Management’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,807,000
Closed -$11.8M – 94
2022
Q3 		$11.8M Sell
2,807,000
-444,048
-14% -$1.74M 0.5% 46
2022
Q2 		$9.07M Buy
3,251,048
+382,000
+13% +$1.53M 0.34% 58
2022
Q1 		$16.4M Buy
2,869,048
+382,708
+15% +$2.8M 0.5% 50
2021
Q4 		$22.7M Buy
2,486,340
+995,900
+67% +$10.2M 0.44% 49
2021
Q3 		$15.9M Hold
1,490,440
– – 0.27% 54
2021
Q2 		$23.1M Buy
1,490,440
+984,403
+195% +$15.7M 0.35% 58
2021
Q1 		$8.2M Buy
+506,037
New +$9.02M 0.12% 79
2020
Q2 		– Sell
-40,500
Closed -$475K – 93
2020
Q1 		$475K Buy
+40,500
New +$761K 0.01% 62

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return